DCTN1-related neurodegeneration

Perry syndrome and beyond

Takuya Konno, Owen A Ross, Hélio A.G. Teive, Jarosław Sławek, Dennis W Dickson, Zbigniew K Wszolek

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Perry syndrome (PS) is a rare hereditary neurodegenerative disease characterized by autosomal dominant parkinsonism, psychiatric symptoms, weight loss, central hypoventilation, and distinct TDP-43 pathology. The mutated causative gene for PS is DCTN1, which encodes the dynactin subunit p150Glued. Dynactin is a motor protein involved in axonal transport; the p150Glued subunit has a critical role in the overall function. Since the discovery of DCTN1 in PS, it has been increasingly recognized that DCTN1 mutations can exhibit more diverse phenotypes than previously thought. Progressive supranuclear palsy- and/or frontotemporal dementia-like phenotypes have been associated with the PS phenotypes. In addition, DCTN1 mutations were identified in a family with motor-neuron disease before the discovery in PS. In this review, we analyze the clinical and genetic aspects of DCTN1-related neurodegeneration and discuss its pathogenesis. We also describe three families with PS, Canadian, Polish, and Brazilian. DCTN1 mutation was newly identified in two of them, the Canadian and Polish families. The Canadian family was first described in late 1970's but was never genetically tested. We recently had the opportunity to evaluate this family and to test the gene status of an affected family member. The Polish family is newly identified and is the first PS family in Poland. Although still rare, DCTN1-related neurodegeneration needs to be considered in a differential diagnosis of parkinsonian disorders, frontotemporal dementia, and motor-neuron diseases, especially if there is family history.

Original languageEnglish (US)
JournalParkinsonism and Related Disorders
DOIs
StateAccepted/In press - Mar 27 2017

Fingerprint

Frontotemporal Dementia
Motor Neuron Disease
Parkinsonian Disorders
Phenotype
Mutation
Nervous System Heredodegenerative Disorders
Progressive Supranuclear Palsy
Perry Syndrome
Hypoventilation
Axonal Transport
Poland
Genes
Psychiatry
Weight Loss
Differential Diagnosis
Pathology
Proteins
Dynactin Complex

Keywords

  • Atypical parkinsonism
  • DCTN1
  • Dynactin
  • FTD
  • Genetics
  • Perry syndrome
  • PSP
  • Review
  • TDP-43

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this

DCTN1-related neurodegeneration : Perry syndrome and beyond. / Konno, Takuya; Ross, Owen A; Teive, Hélio A.G.; Sławek, Jarosław; Dickson, Dennis W; Wszolek, Zbigniew K.

In: Parkinsonism and Related Disorders, 27.03.2017.

Research output: Contribution to journalArticle

@article{35daa36986484399876fe74c054a2d5d,
title = "DCTN1-related neurodegeneration: Perry syndrome and beyond",
abstract = "Perry syndrome (PS) is a rare hereditary neurodegenerative disease characterized by autosomal dominant parkinsonism, psychiatric symptoms, weight loss, central hypoventilation, and distinct TDP-43 pathology. The mutated causative gene for PS is DCTN1, which encodes the dynactin subunit p150Glued. Dynactin is a motor protein involved in axonal transport; the p150Glued subunit has a critical role in the overall function. Since the discovery of DCTN1 in PS, it has been increasingly recognized that DCTN1 mutations can exhibit more diverse phenotypes than previously thought. Progressive supranuclear palsy- and/or frontotemporal dementia-like phenotypes have been associated with the PS phenotypes. In addition, DCTN1 mutations were identified in a family with motor-neuron disease before the discovery in PS. In this review, we analyze the clinical and genetic aspects of DCTN1-related neurodegeneration and discuss its pathogenesis. We also describe three families with PS, Canadian, Polish, and Brazilian. DCTN1 mutation was newly identified in two of them, the Canadian and Polish families. The Canadian family was first described in late 1970's but was never genetically tested. We recently had the opportunity to evaluate this family and to test the gene status of an affected family member. The Polish family is newly identified and is the first PS family in Poland. Although still rare, DCTN1-related neurodegeneration needs to be considered in a differential diagnosis of parkinsonian disorders, frontotemporal dementia, and motor-neuron diseases, especially if there is family history.",
keywords = "Atypical parkinsonism, DCTN1, Dynactin, FTD, Genetics, Perry syndrome, PSP, Review, TDP-43",
author = "Takuya Konno and Ross, {Owen A} and Teive, {H{\'e}lio A.G.} and Jarosław Sławek and Dickson, {Dennis W} and Wszolek, {Zbigniew K}",
year = "2017",
month = "3",
day = "27",
doi = "10.1016/j.parkreldis.2017.06.004",
language = "English (US)",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - DCTN1-related neurodegeneration

T2 - Perry syndrome and beyond

AU - Konno, Takuya

AU - Ross, Owen A

AU - Teive, Hélio A.G.

AU - Sławek, Jarosław

AU - Dickson, Dennis W

AU - Wszolek, Zbigniew K

PY - 2017/3/27

Y1 - 2017/3/27

N2 - Perry syndrome (PS) is a rare hereditary neurodegenerative disease characterized by autosomal dominant parkinsonism, psychiatric symptoms, weight loss, central hypoventilation, and distinct TDP-43 pathology. The mutated causative gene for PS is DCTN1, which encodes the dynactin subunit p150Glued. Dynactin is a motor protein involved in axonal transport; the p150Glued subunit has a critical role in the overall function. Since the discovery of DCTN1 in PS, it has been increasingly recognized that DCTN1 mutations can exhibit more diverse phenotypes than previously thought. Progressive supranuclear palsy- and/or frontotemporal dementia-like phenotypes have been associated with the PS phenotypes. In addition, DCTN1 mutations were identified in a family with motor-neuron disease before the discovery in PS. In this review, we analyze the clinical and genetic aspects of DCTN1-related neurodegeneration and discuss its pathogenesis. We also describe three families with PS, Canadian, Polish, and Brazilian. DCTN1 mutation was newly identified in two of them, the Canadian and Polish families. The Canadian family was first described in late 1970's but was never genetically tested. We recently had the opportunity to evaluate this family and to test the gene status of an affected family member. The Polish family is newly identified and is the first PS family in Poland. Although still rare, DCTN1-related neurodegeneration needs to be considered in a differential diagnosis of parkinsonian disorders, frontotemporal dementia, and motor-neuron diseases, especially if there is family history.

AB - Perry syndrome (PS) is a rare hereditary neurodegenerative disease characterized by autosomal dominant parkinsonism, psychiatric symptoms, weight loss, central hypoventilation, and distinct TDP-43 pathology. The mutated causative gene for PS is DCTN1, which encodes the dynactin subunit p150Glued. Dynactin is a motor protein involved in axonal transport; the p150Glued subunit has a critical role in the overall function. Since the discovery of DCTN1 in PS, it has been increasingly recognized that DCTN1 mutations can exhibit more diverse phenotypes than previously thought. Progressive supranuclear palsy- and/or frontotemporal dementia-like phenotypes have been associated with the PS phenotypes. In addition, DCTN1 mutations were identified in a family with motor-neuron disease before the discovery in PS. In this review, we analyze the clinical and genetic aspects of DCTN1-related neurodegeneration and discuss its pathogenesis. We also describe three families with PS, Canadian, Polish, and Brazilian. DCTN1 mutation was newly identified in two of them, the Canadian and Polish families. The Canadian family was first described in late 1970's but was never genetically tested. We recently had the opportunity to evaluate this family and to test the gene status of an affected family member. The Polish family is newly identified and is the first PS family in Poland. Although still rare, DCTN1-related neurodegeneration needs to be considered in a differential diagnosis of parkinsonian disorders, frontotemporal dementia, and motor-neuron diseases, especially if there is family history.

KW - Atypical parkinsonism

KW - DCTN1

KW - Dynactin

KW - FTD

KW - Genetics

KW - Perry syndrome

KW - PSP

KW - Review

KW - TDP-43

UR - http://www.scopus.com/inward/record.url?scp=85020721807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020721807&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2017.06.004

DO - 10.1016/j.parkreldis.2017.06.004

M3 - Article

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

ER -